Amazon Prime Video is testing another new generative AI-powered feature to help catch you up on a show you’ve been watching before starting a new season. Video Recaps uses AI to identify a show’s ...

Amazon Prime Video is rolling out AI-generated Video Recaps that quickly bring you up to speed on past episodes without rewatching entire seasons. The new feature uses real clips, audio, and ...

Expert DIYer April Wilkerson builds a coffee table with hidden storage to maximize living room space.

Enhance your home effortlessly by learning how to transform your table into a stunning centerpiece with our expert tips! In this video, we unveil easy techniques to achieve a luxurious look without ...

Background: Pay inequality related to social identity has been observed among physicians, even after accounting for hours worked and specialty. Physician identity factors, such as gender and race, may ...

Video Recaps, a first-of-its-kind application of generative AI, provides Prime Video customers with compelling, comprehensive ...

Contests are a great way to expand your brand, and they don’t have to be complicated to be effective. Some of the most successful promotional contests are simple, accessible and highly engaging. These ...

Ovi is an AI model that can create 5-second videos using text alone or text and images. It is open source and can be used for free if you set up your own environment. The generated video is 5 seconds ...

India, EU Narrow Differences As Piyush Goyal Wraps High-Stakes Brussels Push For Swift Trade Deal India’s push for a landmark free trade pact with Europe has entered crunch time. Commerce Minister ...

These questions come from my Udemy training and the certificationexams.pro website, resources that have helped many students pass the DP-100 certification. These are not DP-100 exam dumps or ...

Alkermes plc (Nasdaq: ALKS) ("Alkermes") and Avadel Pharmaceuticals plc (Nasdaq: AVDL) ("Avadel") today announced that the companies have reached agreement on the terms of an increased recommended ...

Significant market opportunities in diabetic retinopathy therapeutics include the unmet need for innovative treatments beyond anti-VEGF therapies, leveraging a robust pipeline with 140 molecules.